Adam develops and leads cross-sector collaborations to address global unmet health needs. By partnering with international agencies, governments and non-government organizations, BD works to address specific health goals which include improving pandemic preparedness, strengthening clinical and laboratory practices, safely immunizing children, addressing infectious and non-communicable diseases, combating antimicrobial resistance and improving safety for health workers and patients.

Adam is currently driving BD’s policy efforts in response to COVID-19 and its impact on pandemic preparedness efforts globally.  This cross-company initiative includes measures to enhance supply chain resiliency, expand surveillance and improve access to vaccinations and testing capabilities in response to current and future threats.

Adam has previously held role in strategy, R&D and innovation at BD, most recently leading BD’s efforts to combat antimicrobial resistance (AMR).  He is a board director of North Carolina BIO and the AMR Industry Alliance and holds a Ph.D. in Polymer Science and Engineering and a B.S. in Chemistry.